CONCLUSIONS	In chronic kidney disease patients with residual proteinuria despite combined angiotensin-converting enzyme inhibitor and angiotensin receptor blockade therapy , add-on fluvastatin does not affect urinary proteins , but further reduces serum lipids and is safe .\